where HDL-C is HDL-cholesterol. Beta-quantification, the most frequently used ultracentrifugation-based method to estimate LDL-C, includes all cholesterol associated with LDL, as well as cholesterol associated with lipoprotein(a) [Lp(a)] and intermediate-density lipoprotein (IDL) particles (4 ) . Because beta-quantification is cumbersome and requires sophisticated equipment, most clinical laboratories use the Friedewald formula, which also includes LDL-C, IDL-cholesterol, and Lp(a)-cholesterol in the estimation of LDL-C. Although chylomicronemia and increased concentrations of VLDL and IDL particles are known to interfere with the Friedewald formula, unacceptable bias may also be found with triglyceride (Tg) concentrations Ͻ4.6 mmol/L (4, 5 ) . Therefore, direct methods that reliably measure LDL-C would be of great interest in clinical practice.
Since the first introduction of an immunochemically based method (6 ), other methods based on the selective solubilization of LDL particles have also been reported (7 ) . When compared with beta-quantification, most of these methods show a certain bias (8 -10 ) , which could be caused by unequal reactivity of reagents with the broad range of plasma lipoproteins estimated as LDL by commonly used procedures. Thus, before a direct method can be introduced into clinical practice, the cholesterol fraction(s) measured and its equivalence with beta-quantification must be evaluated. In this study, we assessed LDL-C Plus, a direct, homogeneous method for the measurement of LDL-C, and analyzed which lipoproteins are recognized as LDL.
The LDL-C Plus assay (cat. no. 1985604; Roche Diagnostics) was used according to manufacturer instructions and calibrated with the calibrator provided by the manufacturer. The principle of the method has been described elsewhere (8 -10 ) . In the first step, a mixture of Mg 2ϩ , sulfated ␣-cyclodextrin, and dextran sulfate was used to reduce the reactivity of chylomicrons and VLDL-cholesterol (VLDL-C) with the enzymes used in the final reaction.
Total cholesterol (TC) and Tg concentrations were measured by standard enzymatic methods (CHOD-PAP and GPO-PAP; Roche Diagnostics). HDL-C was measured by a direct method, and Lp(a) concentrations were measured by immunoturbidimetry (both from Roche Diagnostics). All assays were performed in an Hitachi 911 analyzer. LDL-C was determined by the Friedewald formula (LDL F ) and by modified beta-quantification (LDL BQ ), VLDL was separated at d Ͻ1.006 kg/L by ultracentrifugation (18 h; 105 000g; 4°C), and HDL-C was measured in the infranatant by the direct method (instead of precipitation). During the period of the study (October-December 1999), the inaccuracies of TC, Tg, direct HDL, and LDL BQ measurements were controlled by a multilevel control from the Pacific Biometrics Research Foundation. Maximum inaccuracies were 2.2%, Ϫ4.4%, and Ϫ4.5% for TC, Tg, and direct HDL-C, respectively, whereas the inaccuracy for LDL BQ was 1.6 -7.5%. Lipoprotein fractions were isolated by sequential ultracentrifugation from pooled sera using the following densities: d Ͻ0.95 kg/L for chylomicrons, 0.95-1.006 kg/L for VLDL, 1.006 -1.019 kg/L for IDL, 1.019 -1.050 kg/L for LDL, 1.050 -1.100 kg/L for Lp(a), and Ͼ1.100 kg/L for HDL and the lipoprotein-deficient serum fraction. The range 1.019 -1.050 kg/L was selected for LDL to avoid the inclusion of Lp(a) particles in this fraction. TC content in these fractions was measured as indicated above.
With commercial controls containing two different LDL-C concentrations (Precinorm ® L and Precipath ® HDL/LDL; Roche Diagnostics), LDL-C Plus showed a run-to-run imprecision of Ͻ2.0%, which satisfied criteria established by the National Cholesterol Education Program (5 ). Recovery and serial dilutions of isolated LDL produced direct inaccuracy estimates of Ͻ5.1%. When LDL-C Plus was assessed in samples with chylomicrons and/or increased VLDL (n ϭ 9), a positive difference was found (3.07 Ϯ 1.73 mmol/L for LDL-C vs 2.71 Ϯ 1.58 mmol/L for LDL BQ ; P Ͻ0.0001, Wilcoxon t-test). However, when one sample with a serum VLDL-C/Tg ratio of 1.05 (in mmol/L) was excluded from analysis, the difference became negative (2.24 Ϯ 0.93 mmol/L for LDL-C Plus vs 2.37 Ϯ 1.00 mmol/L for LDL BQ ; P Ͻ0.0001). These results suggest a strong dependence of LDL-C Plus values on serum VLDL-C/Tg (i.e., on serum IDL particle content).
Passing-Bablok regression analysis ( This constant error has been described recently (9, 10 ) and persisted after the samples were classified according to whether Tg concentrations were lower (n ϭ 64) or higher (n ϭ 51) than 2.30 mmol/L. LDL-C Plus values were not correlated with Tg [Spearman correlation coefficient (r S ) ϭ 0.08], VLDL-C (r S ϭ 0.004, obtained by the reference method), or HDL-C (Pearson correlation coefficient, r ϭ 0.12), but a significant positive association was found with the serum VLDL-C/Tg ratio (r S ϭ 0.28; P ϭ 0.002). Again, these results suggest a relationship between LDL-C Plus and serum IDL-C content. In these samples, the Friedewald formula also produced significantly lower values (3.19 Ϯ 1.04 mmol/L; P Ͻ0.0001) and a negative bias (LDL F ϭ Ϫ0.225 ϩ 1.017 ϫ LDL BQ ). In a subset of samples (n ϭ 24) in which Lp(a) was measured, no significant association (r S ϭ 0.02) was found between the Lp(a) logarithm and LDL-C Plus values.
To ascertain whether the negative bias of the LDL-C Plus method was related to a differential reactivity of the reagents with various serum lipoproteins, we investigated the amount of cholesterol that was measured by the LDL-C Plus assay in two pooled sera. The reactivities of these sera with LDL-C Plus are depicted in Fig. 1 . VLDL-C did not react significantly with LDL-C Plus, IDL-C showed Ͼ60% reactivity in both pools, LDL-C showed the highest reaction (70 -80%), and the Lp(a) fraction with a density of 1.050 -1.100 kg/L had a reactivity of ϳ35%. The reactivity of the latter fraction could be attributable to the presence of LDL particles in this density range, but not to the presence of Lp(a) particles because reactivities in this fraction did not vary between pooled sera with undetectable (Ͻ80 mg/L) and high (729 mg/L) Lp(a) concentrations. No detectable reactivity was found in the HDL ϩ lipoprotein-deficient serum fraction. Our results are in accordance with previous observations (12) (13) (14) . A method that uses the same mixture of Mg 2ϩ ions, ␣-cyclodextrin, and dextran sulfate as LDL-C Plus to decrease the reactivity of chylomicron-cholesterol and VLDL-C measures almost 80% of the cholesterol associated with IDL particles (12 ) . Indeed, Lackner et al. (13 ) , in dysbetalipoproteinemic patients, and we, in hyperlipidemic genetically modified mice with very high IDL content (14 ) , have shown that these particles are recognized by the HDL-C direct assay from Roche, which produces a positive bias.
Both the Roche HDL and LDL direct assays essentially share the same mixture as first reagent (12, 15 ) . Thus, both the previous and the present results demonstrate that this mixture does not eliminate the reactivity of IDL-C. This failure to eliminate the reactivity of IDL-C, which interferes in HDL-C measurement, allows the recognition of most IDL-C as LDL-C with the LDL-C Plus method, as occurs with the Friedewald equation and beta-quantification.
According to these data, LDL-C Plus mainly recognized cholesterol associated with LDL and IDL, but not with Lp(a); the latter being strikingly different from LDL BQ and LDL F . However, the contribution of Lp(a) to TC is Ͻ0.2-0.3 mmol/L in subjects with Lp(a) concentrations Ͻ300 mg/L (16, 17 ) . Thus, the substantial differences found between LDL-C Plus and LDL BQ are independent of which lipoprotein-cholesterol is recognized by the assay.
To elucidate the role of calibration in the negative bias of LDL-C Plus, we assessed 68 additional serum samples The confidence intervals for the slope and y-intercept included 1 and 0, respectively. LDL-C Plus and LDL BQ concentrations were not significantly different (3.63 Ϯ 1.34 mmol/L for LDL-C Plus and 3.71 Ϯ 1.30 mmol/L for LDL BQ ), but in the same samples, LDL F was significantly lower (3.27 Ϯ 1.47 mmol/L; P Ͻ0.001). Of samples with Ͻ4.6 mmol/L and Ն4.6 mmol/L Tg, 81% and 45%, respectively, had a bias lower than 10% according to LDL-C Plus, whereas 79% and 18% showed this bias according to LDL F . Thus, it is likely that the differences found between LDL-C Plus and LDL BQ could be attributed to the calibration of the assay. This has also been suggested by two recent studies (9, 10 ) , but our data show, for the first time, the reactivity of LDL-C Plus reagents with the broad range of lipoproteins estimated as LDL by currently used methods.
In conclusion, we demonstrate that the LDL-C Plus assay measures cholesterol associated with IDL and LDL but not with Lp(a) particles. The significant negative bias observed may be attributed to suboptimal assay calibration. After readjusting the calibration, we found a close relationship between LDL-C Plus and LDL BQ values, and LDL-C Plus became a reliable alternative to beta-quantification and a better approach for LDL-C measurement than the Friedewald formula.
